CryoPort

CYRX · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 28 days ago

Total Revenue

$45.5M

Previous year: $59.5M

-23.7%

EPS

-$0.171

Previous year: -$0.42

-59.2%

Commercial Cell & Gene Therapy Revenue

$33.4M

Adjusted EBITDA

-$1.4M

Global Clinical Trials Supported

760

Gross Profit

$21.7M

Previous year: $27.3M

-20.4%

Cash and Equivalents

$250M

Previous year: $45.3M

Loading...

CryoPort

Unlock previous datapoints

Upgrade

CryoPort

Unlock previous datapoints

Upgrade

CryoPort Revenue by Segment

Revenue by Segment

Life Sciences Services Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

BioLogistics Solutions Revenue

CapyFin.com

BioStorage/BioServices Revenue

CapyFin.com

Life Sciences Products Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$390M

P/E Ratio

5.51

Sector

N/A

Industry

N/A

52-Week High

$11.3

52-Week Low

$4.93

Commercial Cell & Gene Therapy Revenue

$33.4M

Adjusted EBITDA

-$1.4M

Global Clinical Trials Supported

760

Phase 1 Clinical Trials

313

Phase 2 Clinical Trials

361

Products

Get in Touch

Resources

CryoPort

CryoPort

CryoPort

CryoPort Revenue by Segment

Revenue by Segment

Life Sciences Services Revenue

BioLogistics Solutions Revenue

BioStorage/BioServices Revenue

Life Sciences Products Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics